Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Project lead: Professor Simon de Lusignan

Research Group:

Funding: European Commission

Many partners, already involved in studies within the I-MOVE (Influenza – Monitoring Vaccine Effectiveness in Europe) network, came together as the I-MOVE-COVID-19 consortium, and were successful in a bid for the European Commission H2020 call on “Advancing knowledge for the clinical and public health response to the novel coronavirus epidemic”.

The I-MOVE-COVID-19 consortium aims to obtain epidemiological and clinical information on patients with COVID-19 as well as virological information on SARS-CoV-2, through (a) provision of a flexible surveillance platform (adaptable to the epidemiological situation), (b) research studies and (c) evaluation of public health interventions (e.g. vaccination, antivirals), in order to contribute to the knowledge base, guide patient management, and inform the public health response. This will be achieved through adaptation and expansion of the existing, long-running, Europe-wide influenza surveillance network (I-MOVE) to include COVID-19. The network includes primary care networks, hospitals, and national laboratory reference centres in 10 countries across the WHO European Region.